Julie Papanek Grant is a partner at Canaan where she leads early investments in biopharmaceuticals and digital health. Canaan has founded and funded numerous start-ups focused on novel CNS and pain interventions including Labrys, Spinifex, Arrakis, Semnur, Chrono Therapeutics, and Civitas. Mrs. Papanek Grant brings deep operational experience to her biopharma and digital health investments, having previously worked at Genentech across development and commercial divisions. Julie serves on the board of the Biden Cancer Initiative and co-chairs Planned Parenthood NorCal’s IT Advisory Board. In 2017, she was named one of Silicon Valley Business Times’ 40 Under 40. Julie holds an M.B.A. from Stanford, an MPhil. in BioScience Enterprise from Cambridge and a B.S. in Molecular Biophysics and Biochemistry from Yale.